{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T11:01:02Z","timestamp":1766401262546},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,30]]},"DOI":"10.7759\/cureus.33145","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T18:36:06Z","timestamp":1672425366000},"source":"Crossref","is-referenced-by-count":3,"title":["Risk Factors of Rhino Orbital Mucormycosis"],"prefix":"10.7759","author":[{"given":"Yugandhara","family":"Patade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"G","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: mucormycosis in COVID-19 times","volume":"69","author":"Ravani SA","year":"2021","unstructured":"Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021, 69:1563-8. 10.4103\/ijo.IJO_310_21","journal-title":"Indian J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-021-00845-5","article-title":"Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations","volume":"65","author":"Bayram N","year":"2021","unstructured":"Bayram N, Ozsayg\u0131l\u0131 C, Sav H, et al.. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations. Jpn J Ophthalmol. 2021, 65:515-25. 10.1007\/s10384-021-00845-5","journal-title":"Jpn J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2012.669502","article-title":"Risk factors for mortality in patients with mucormycosis","volume":"50","author":"Spellberg B","year":"2012","unstructured":"Spellberg B, Kontoyiannis DP, Fredricks D, et al.. Risk factors for mortality in patients with mucormycosis. Med Mycol. 2012, 50:611-8. 10.3109\/13693786.2012.669502","journal-title":"Med Mycol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta S","year":"2020","unstructured":"Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus. 2020, 12:e10726. 10.7759\/cureus.10726","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2014.12.002","article-title":"Invasive rhino-orbito-cerebral mucormycosis in a diabetic patient - the need for prompt treatment","volume":"8","author":"Chow V","year":"2015","unstructured":"Chow V, Khan S, Balogun A, Mitchell D, M\u00fchlschlegel FA. Invasive rhino-orbito-cerebral mucormycosis in a diabetic patient - the need for prompt treatment. Med Mycol Case Rep. 2015, 8:5-9. 10.1016\/j.mmcr.2014.12.002","journal-title":"Med Mycol Case Rep"},{"key":"ref6","article-title":"Rhino-orbital Cerebral Mucormycosis","author":"AK AK","year":"2022","unstructured":"AK AK, Gupta V. Rhino-orbital Cerebral Mucormycosis. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1288\/00005537-198210000-00007","article-title":"Rhinocerebral mucormycosis: predisposing factors","volume":"92","author":"McNulty JS","year":"1982","unstructured":"McNulty JS. Rhinocerebral mucormycosis: predisposing factors. Laryngoscope. 1982, 92:1140-3.","journal-title":"Laryngoscope"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.645270","article-title":"Spike in rhino-orbital-cerebral mucormycosis cases presenting to a tertiary care center during the COVID-19 pandemic","volume":"8","author":"Fouad YA","year":"2021","unstructured":"Fouad YA, Abdelaziz TT, Askoura A, Saleh MI, Mahmoud MS, Ashour DM, Ashour MM. Spike in rhino-orbital-cerebral mucormycosis cases presenting to a tertiary care center during the COVID-19 pandemic. Front Med. 2021, 8:645270. 10.3389\/fmed.2021.645270","journal-title":"Front Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-007-0066-4","article-title":"Zygomycosis: an emerging fungal infection with new options for management","volume":"9","author":"Kauffman CA","year":"2007","unstructured":"Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep. 2007, 9:435-40. 10.1007\/s11908-007-0066-4","journal-title":"Curr Infect Dis Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020, 395:507-13. 10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: we should be prepared","volume":"30","author":"Gangneux JP","year":"2020","unstructured":"Gangneux JP, Bougnoux ME, Dannaoui E, Cornet M, Zahar JR. Invasive fungal diseases during COVID-19: we should be prepared. J Mycol Med. 2020, 30:100971. 10.1016\/j.mycmed.2020.100971","journal-title":"J Mycol Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1977.00780270068011","article-title":"Rhinocerebral mucormycosis","volume":"103","author":"Pillsbury HC","year":"1977","unstructured":"Pillsbury HC, Fischer ND. Rhinocerebral mucormycosis. Arch Otolaryngol. 1977, 103:600-4. 10.1001\/archotol.1977.00780270068011","journal-title":"Arch Otolaryngol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo study (2005-2007)","volume":"54 Suppl 1","author":"Lanternier F","year":"2012","unstructured":"Lanternier F, Dannaoui E, Morizot G, et al.. A global analysis of mucormycosis in France: the RetroZygo study (2005-2007). Clin Infect Dis. 2012, 54 Suppl 1:S35-43. 10.1093\/cid\/cir880","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2366_21","article-title":"A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis","volume":"70","author":"Mani S","year":"2022","unstructured":"Mani S, Thirunavukkarasu A. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis. Indian J Ophthalmol. 2022, 70:1013-8. 10.4103\/ijo.IJO_2366_21","journal-title":"Indian J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1470-9465.2004.00843.x","article-title":"Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment","volume":"10 Suppl 1","author":"Prabhu RM","year":"2004","unstructured":"Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004, 10 Suppl 1:31-47. 10.1111\/j.1470-9465.2004.00843.x","journal-title":"Clin Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.5.741","article-title":"Disseminated zygomycosis: report of four cases and review","volume":"11","author":"Ingram CW","year":"1989","unstructured":"Ingram CW, Sennesh J, Cooper JN, Perfect JR. Disseminated zygomycosis: report of four cases and review. Rev Infect Dis. 1989, 11:741-54. 10.1093\/clinids\/11.5.741","journal-title":"Rev Infect Dis"},{"key":"ref17","article-title":"Mucormycosis among patients on dialysis","volume":"321","author":"Boelaert JR","year":"1989","unstructured":"Boelaert JR, Fenves AZ, Coburn JW. Mucormycosis among patients on dialysis. N Engl J Med. 1989, 321:190-1.","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(89)80836-8","article-title":"Mucormycosis: association with deferoxamine therapy","volume":"468","author":"Daly AL","year":"1989","unstructured":"Daly AL, Velazquez LA, Bradley SF, et al.. Mucormycosis: association with deferoxamine therapy. Am J Med. 1989, 468:7. 10.1016\/s0002-9343(89)80836-8","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/01.iop.0000225418.50441.ee","article-title":"Indications for orbital exenteration in mucormycosis","volume":"22","author":"Hargrove RN","year":"2006","unstructured":"Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG. Indications for orbital exenteration in mucormycosis. Ophthalmic Plast Reconstr Surg. 2006, 22:286-91. 10.1097\/01.iop.0000225418.50441.ee","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129143-risk-factors-of-rhino-orbital-mucormycosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:54Z","timestamp":1707508014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129143-risk-factors-of-rhino-orbital-mucormycosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.33145","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}